Novartis appoints new comms head; Jerome Bettis and Sanofi want to know your 'AQ';

> Novartis ($NVS) has appointed Michael Willi as its group head of communications. More

> Four alcoholism meds worked to reduce addiction, a study found, which could dispel skepticism and spur greater use of the drugs. Report

> Amgen ($AMGN) is honoring four cancer survivors as part of its "Breakaway from Cancer" initiative. Release

> Novartis UK has launched a new mobile app that allows multiple sclerosis patients to track their symptoms and relapses. More

> A Johnson & Johnson ($JNJ) advertisement for a yogurt drink has been banned for exaggerating the product's health benefits. More

And Finally... Sanofi ($SNY) has signed on former NFL star Jerome Bettis to help it launch an anaphylaxis quiz during National Asthma and Allergy Awareness Month. Release

Suggested Articles

Novartis hopes to leverage its existing presence in the hematology community to achieve a successful launch of Adakveo.

Compared with the FDA "boxed warning," the EMA version puts a smaller restriction on the higher dose but broadens the cautionary language.

To show Brukinsa is better than AbbVie and J&J's blockbuster Imbruvica, BeiGene is running phase 3 head-to-head trials in blood cancers.